IDYA

IDEAYA BIOSCIENCES INC

IDYA·45166A102·US·Common Stock·Healthcare - Biotechnology-13D/G

IDYA (IDEAYA BIOSCIENCES INC) is held by 134 institutional investors as of Q1 2026. Largest holders: FMR LLC ($438.9M), BlackRock, Inc. ($281.3M), Janus Henderson Group Ltd. ($242M). Net institutional sentiment: Mixed.

134
Holders
(10 Elite)
$2.7B
Total Value
53% (139)
Consensus
74 buying - 65 selling
13F: Insider & Congress:
IDYASmart Money Verdict
View all
Held by 134 funds
10 elite
Who's Trading
InsiderRARuiz Briseno AndresSell $382KJul 7, 2026
ActivistJANUS HENDERSON GROUP PLCJANUS HENDERSON GROUP PLC8.3%May 15, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderSJStein JeffreyBuy $1.6MMar 2, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.2.1%Feb 17, 2026
ActivistCapital Research Global InvestorsCapital Research Global Investors6.0%Feb 12, 2026
ActivistFederated Hermes, Inc.Federated Hermes, Inc.3.9%Jan 8, 2026
ActivistBlackRock, Inc.BlackRock, Inc.8.1%Apr 17, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
13.2M(+0.2%)$438.9M0.0%+48.87%
31
Increased
8.4M(+2.8%)$281.3M0.0%+50.15%
32
Increased
7.3M(+1.1%)$242M0.1%+27.39%
37
Decreased
5.2M(-2.2%)$172M0.0%+52.25%
0
Increased
3.9M(+9.1%)$131.5M0.8%+54.97%
46
Decreased
3.8M(-8.6%)$126M0.0%+6.83%
0
New
3.7M$124.4M0.0%+7.81%
42
Decreased
3M(-12.0%)$99.5M0.2%+44.41%
0
Increased
2.8M(+0.8%)$94.1M0.1%+51.63%
36
Increased
2.5M(+3.7%)$84.2M0.3%+4.49%
37
Increased
2.5M(+20.6%)$83.3M0.0%+34.35%
35
Increased
1.9M(+48.5%)$62M0.0%+27.18%
41
Decreased
1.7M(-6.5%)$55.2M0.0%+36.91%
0
Increased
1.3M(+42.0%)$44.4M0.0%+20.09%
39
Decreased
1.3M(-9.2%)$43.8M0.0%+30.98%
0
Increased
1.1M(+7.4%)$36.9M0.2%+29.47%
37
Increased
1.1M(+57.8%)$36.7M0.0%+16.62%
41
Increased
942,091(+4.3%)$31.4M0.0%+64.16%
30
Decreased
899,504(-8.1%)$30M0.1%+39.65%
0
Decreased
882,699(-0.8%)$29.4M0.0%+10.59%
0

Showing 1-20 of 147

1 / 8

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used